Congratulations to Dr Arjun Sahgal on leading our multi-centre interdisciplinary RCT published in the Lancet

Published in the Lancet, the  open-label, multi-centre, randomized, controlled, phase 2/3 trial led by Dr. Arjun Sahgal reported that the Stereotactic body radiation therapy (SBRT) was superior to conventional radiation therapy in reducing pain from spinal metastases. The research will have a tremendous impact in changing practice standards for XRT for painful spinal mets.

Read full article in related file above